4.0900
+0.0800
+(2.00%)
At close: April 8 at 4:00:02 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 13 | 12 |
| Avg. Estimate | 0.09 | 0.1 | 0.4 | 0.47 |
| Low Estimate | 0.08 | 0.09 | 0.35 | 0.44 |
| High Estimate | 0.1 | 0.11 | 0.45 | 0.5 |
| Year Ago EPS | 0.08 | 0.08 | 0.34 | 0.4 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 16 | 16 |
| Avg. Estimate | 202.25M | 206.55M | 824.27M | 878.07M |
| Low Estimate | 200M | 204.2M | 812.5M | 850.22M |
| High Estimate | 204.99M | 211.5M | 836.28M | 912.7M |
| Year Ago Sales | 197.88M | 200.61M | 792.32M | 824.27M |
| Sales Growth (year/est) | 2.21% | 2.96% | 4.03% | 6.53% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.08 | 0.09 | 0.09 | 0.1 |
| EPS Actual | 0.08 | 0.08 | 0.08 | 0.09 |
| Difference | 0 | -0.01 | -0.01 | -0.01 |
| Surprise % | 5.58% | -8.39% | -8.23% | -6.11% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.09 | 0.1 | 0.4 | 0.47 |
| 7 Days Ago | 0.09 | 0.1 | 0.4 | 0.46 |
| 30 Days Ago | 0.09 | 0.1 | 0.4 | 0.46 |
| 60 Days Ago | 0.1 | 0.1 | 0.4 | 0.48 |
| 90 Days Ago | 0.1 | 0.1 | 0.4 | 0.48 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 2 | 2 | 6 | 1 |
| Down Last 7 Days | 2 | 2 | -- | 1 |
| Down Last 30 Days | 3 | 2 | 5 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GDRX | 18.55% | 24.97% | 18.43% | 17.57% |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |
| Maintains | Citigroup: Buy to Buy | 1/10/2025 |
| Maintains | Keybanc: Overweight to Overweight | 1/8/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/17/2024 |
| Maintains | Citigroup: Buy to Buy | 11/13/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/11/2024 |
Related Tickers
TDOC Teladoc Health, Inc.
7.16
-0.97%
DOCS Doximity, Inc.
50.71
-3.21%
AMWL American Well Corporation
6.23
-4.74%
EVH Evolent Health, Inc.
9.55
+1.60%
SDGR Schrödinger, Inc.
17.97
-1.32%
TALK Talkspace, Inc.
2.7200
+2.64%
HQY HealthEquity, Inc.
76.77
-4.47%
LFMD LifeMD, Inc.
4.8200
-2.53%
VEEV Veeva Systems Inc.
209.39
-2.49%
CERT Certara, Inc.
9.05
-3.42%